Dear Colleagues,

we are very proud to welcome you to Verona (Italy) for the 32nd Annual Conference of European Macrophage & Dendritic Cell Society (EMDS) entitled The cross-talk between macrophages and dendritic cells: from immunometabolism to single cell fate. The conference will take place on 27-29 September, 2018 at Polo Didattico “G. Zanotto” – Verona, Italy

Myeloid cells comprise different populations of mature, terminally differentiated macrophages, dendritic cells and neutrophils, as well as immature myeloid progenitors. These cells are evolutionarily designed to protect the host from pathogens, such as bacteria and viruses. However, during chronic inflammation-associated diseases, such as cancer, these cells undergo sequential phenotypical changes linked to an alteration of the normal hematopoiesis that promotes the expansion of myeloid cells with negative immune regulatory activity on adaptive immunity.

The specific goals of this meeting are a better understanding of myeloid cells ontogeny, under normal and pathological conditions, a critical analysis of markers and genetic signatures that can partially resolve the definition of their identity, and potential therapeutic approaches able to increase the efficacy of current immunotherapy.

The program is based on 6 specific sections in which 19 excellent scientists will share their exciting research results with us. Moreover, we invited 4 outstanding scientists, whose studies had deeply imprinted the current knowledge about myeloid cells, to deliver a specific keynote lecture during the congress. Finally, we will have a lively poster session providing a great occasion to discuss and socialize with colleagues and we will select 12 abstracts presented by young researchers as short talks. Besides an outstanding scientific program, our meeting will provide opportunities for participants to meet colleagues, build networks, and establish future collaborations.

Therefore, we are very excited to offer this incredible opportunity and are looking forward to an active and professional networking, in addition to vigorous discussion of cutting edge science in the myeloid cell field.

The 2018 Scientific Program Chairs


February 1st 2018: Opening registration and abstract submission
June 15th 2018: Deadline early registration and abstracts submissions
July 13th 2018: Deadline late registration